Metabolic Syndrome and Bioactive Compounds
- Authors: Domingo Ly Pen1, Antonio Becerra2, Miriam Menacho3
-
View Affiliations Hide AffiliationsAffiliations: 1 Croydon UCC, Croydon University Hospital, London, CR7 7YE, United Kingdom 2 Croydon UCC, Croydon University Hospital, London, CR7 7YE, United Kingdom 3 Croydon UCC, Croydon University Hospital, London, CR7 7YE, United Kingdom
- Source: At the Crossroads Between Nutrition and Pharmacology , pp 264-292
- Publication Date: May 2017
- Language: English
Metabolic Syndrome and Bioactive Compounds, Page 1 of 1
< Previous page | Next page > /docserver/preview/fulltext/9781681084299/chapter-11-1.gif
Metabolic syndrome is defined as a set of coexisting metabolic disorders that increase an individuals likelihood of developing type 2 diabetes, cardiovascular disease and stroke, among other chronic diseases. In Chapter 9 of this same book, we have already explained in detail, the main concepts about Mediterranean diet and bioactive compounds and diabetes. In this chapter, we update the evidence about dietary bioactive compounds with potential in preventing / treating the Metabolic Syndrome. We will only focus on the studies where the evidence is relevant, not on the multiple studies in vivo, very interesting indeed, but with no current clinical relevance. Bioactive compounds should be of the greatest interest because of their multiple positive effects on health, prevention of Metabolic Syndrome related diseases or lowering their complications.
-
From This Site
/content/books/9781681084299.chapter-11dcterms_subject,pub_keyword-contentType:Journal105
